Rhythm Pharmaceuticals buy Bank of America Co.
Start price
07.04.25
/
50%
€50.50
Target price
07.04.26
€57.38
Performance (%)
55.45%
Price
27.02.26
€81.50
Summary
This prediction is currently active. The BUY prediction by Bank_of_America_Co_ for Rhythm Pharmaceuticals has seen massive gains of 55.45%. This prediction currently runs until 07.04.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | -4.118% | -4.118% |
| iShares Core DAX® | -0.383% | 1.093% |
| iShares Nasdaq 100 | -0.411% | -1.973% |
| iShares Nikkei 225® | 1.838% | 10.261% |
| iShares S&P 500 | -0.712% | 0.445% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $63.00 price target on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€76.50
10.07.25
10.07.25
€80.90
10.07.26
10.07.26
2.61%
27.02.26
27.02.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€20.80
01.08.23
01.08.23
-
01.08.24
01.08.24
97.12%
02.08.24
02.08.24